FDA chief Rob Califf: The business of health is booming but people's outcomes aren't improving
While referring to himself as living in the proverbial “overtime” of life at the age of 70, newly Senate-confirmed FDA chief Rob Califf said his hope, at the end of his second run at the agency, is to leave the system in a way that enables people to better find out the truth about the risks and benefits of products the FDA regulates.
The famed clinical trialist from Duke, who also recently spent time at Google’s parent company Alphabet, made clear that his vision is to fairly evaluate the real value and worth of new products, and to quickly dispose of investigational products that aren’t useful.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
